EAA and Pharma Patient Websites: Why to Act Before 2030
Patient info sites are outside the European Accessibility Act scope today, but pharma teams risk costly retrofits by waiting. Start WCAG 2.…
Patient info sites are outside the European Accessibility Act scope today, but pharma teams risk costly retrofits by waiting. Start WCAG 2.…
Pharma website accessibility under WCAG 2.2 AA is now law via the European Accessibility Act. See what MSD's hpvinfo.be got right — and her…
Pharma disease-awareness sites systematically fail WCAG 2.2 AA — and the European Accessibility Act makes that a legal risk. Here's what wo…
A pharma website accessibility audit of 80 disease awareness sites revealed contrast failures, broken PDFs, and WCAG gaps hurting vulnerabl…
A design system accessibility audit fixes WCAG failures in tokens and components before they spread across every pharma site. Here's what w…
A custom Figma plugin for pharma design systems enforces brand tokens, WCAG 2.2, and MLR rules at source — cutting review rounds from weeks…
A WCAG audit for a pharma website tests every page across four real user scenarios, groups fixes by root cause, and prioritises by patient…
A WCAG 2.2 audit of a pharma patient website reveals five critical barriers on a rare disease site — contrast, focus, alt text, and more. H…
A pharma website accessibility audit reveals the same structural failures every time—broken palettes, untagged PDFs, skip-level headings. H…
A WCAG audit of a pharma website checks EN 301 549 compliance under the European Accessibility Act — colour contrast, PDFs, cookie banners,…
A WCAG audit pharma disease awareness website must pass under the European Accessibility Act from June 2025—here's what a rigorous audit ac…
A pharma website WCAG accessibility audit of Amgen Belgium's osteoporosenews.be uncovered 11 critical barriers blocking screen-reader users…
One short email when we publish. No spam, no sales pitch. Unsubscribe whenever.